Agios Pharmaceuticals Inc (AGIO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Agios Pharmaceuticals Inc   (NASDAQ: AGIO)
 

Agios Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Agios Pharmaceuticals Inc inventory turnover ratio, the Agios Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.23 in the second quarter 2026, yet the ratio remained below the average, as AGIO's market remain challenging.Average inventory processing period, for the Agios Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 1587 days, compare to 1825 days, in the Mar 31 2026 quarter.

Within Healthcare sector 368 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1163 in the first quarter 2026, to 1972.

AGIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Agios Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGIO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 15.9 % 18.52 % 19.21 % 21.21 % 28.87 %
Y / Y Cost of Sales Growth 76.03 % 21.57 % 49.13 % 114.43 % 13.85 %
Inventory Turnover Ratio (TTM) 0.23 0.2 0.2 0.19 0.17
AGIO's Total Ranking # 1972 # 1163 # 1160 # 1662 # 518
Average inventory processing period 1574 1815 1804 1914 2163
Seq. Inventory Growth 1.9 % 6.58 % 2.77 % 3.84 % 4.2 %
Seq. Cost of Sales Growth 127.14 % -29.8 % 11.91 % -1.35 % 56.87 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 116
Healthcare Sector # 369
Overall Market # 1972

Inventory Turnover Ratio Statistics
High Average Low
0.93 0.26 0.15
(Jun 30 2019)   (Sep 30 2024)



AGIO Company Profile >> Back to AGIO Efficiency Comparisons >> Compare AGIO Inventory Turnover Ratio to its Competitors

Financial Statements
Agios Pharmaceuticals Inc 's Inventories $ 36 Millions Visit AGIO's Balance sheet
Agios Pharmaceuticals Inc 's Cost of Revenues TTM $ 8 Millions Visit AGIO's Income Statement
What are AGIO's Sales? Visit AGIO's Sales by Segment

Other Inventory Turnover Ratios
Agios Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AGIO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AGIO's Competitors
Inventory Turnover Ratio for AGIO's Suppliers
Inventory Turnover Ratio for AGIO's Customers

You may also want to know
AGIO's Sales Growth Rates AGIO's Pe Price to earnings ratio AGIO's Receivables Turnover Ratio AGIO's Stock Quote
AGIO's Net Income Growth Rates AGIO's Ps Price to Sales ratio AGIO's Sales per Employee AGIO's Asset Turnover Ratio
AGIO's Net Margin AGIO's Pb Price to Book ratio AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Jaguar Health Inc   0.57 $ 4.921  Millions$ 9  Millions
Travere Therapeutics Inc   0.57 $ 8.263  Millions$ 14  Millions
Cvrx inc   0.57 $ 6.981  Millions$ 12  Millions
Biomarin Pharmaceutical Inc  0.57 $ 813.588  Millions$ 1,434  Millions
Verastem Inc   0.54 $ 1.128  Millions$ 2  Millions
Ionis Pharmaceuticals Inc   0.53 $ 9.873  Millions$ 19  Millions
Heron Therapeutics Inc   0.53 $ 45.572  Millions$ 86  Millions
Orchestra Biomed Holdings Inc   0.52 $ 0.157  Millions$ 0  Millions
Sintx Technologies Inc   0.51 $ 0.627  Millions$ 1  Millions
Siga Technologies Inc  0.50 $ 24.494  Millions$ 49  Millions
Ardelyx inc   0.50 $ 25.401  Millions$ 51  Millions
Regeneron Pharmaceuticals Inc   0.49 $ 1,549.600  Millions$ 3,161  Millions
Orthopediatrics Corp  0.49 $ 65.142  Millions$ 134  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Agios Pharmaceuticals Inc   0.23 $ 7.873  Millions$ 34  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Madrigal Pharmaceuticals Inc   0.12 $ 10.400  Millions$ 89  Millions

Date modified: 2026-09-13T23:38:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.